Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Characteristics of the complement system gene expression deficiency in patients with symptomatic pulmonary embolism.

Lv W, Wang L, Duan Q, Gong Z, Yang F, Song H, Song Y.

Thromb Res. 2013 Jul;132(1):e54-7. doi: 10.1016/j.thromres.2013.04.027. Epub 2013 May 30.

PMID:
23726092
2.

Gene expression levels of cytokines in peripheral blood mononuclear cells from patients with pulmonary embolism.

Lv W, Duan Q, Wang L, Gong Z, Yang F, Song Y.

Mol Med Rep. 2013 Apr;7(4):1245-50. doi: 10.3892/mmr.2013.1344. Epub 2013 Feb 26.

PMID:
23447056
3.

Differential expression of leukocyte β2 integrin signal transduction‑associated genes in patients with symptomatic pulmonary embolism.

Yun J, Duan Q, Wang L, Lv W, Gong Z, Yang F, Song Y.

Mol Med Rep. 2014 Jan;9(1):285-92. doi: 10.3892/mmr.2013.1780. Epub 2013 Nov 7.

PMID:
24213151
4.

[The expression of interferon associated genes mRNA in patients with pulmonary embolism].

Lü W, Wang LM, Gong Z, Wang Q, Gao HJ, Shen XY.

Zhonghua Nei Ke Za Zhi. 2012 Apr;51(4):270-3. Chinese.

PMID:
22781945
5.

Expression of B-cell-associated genes in peripheral blood mononuclear cells of patients with symptomatic pulmonary embolism.

Lv W, Duan Q, Wang L, Gong Z, Yang F, Song Y.

Mol Med Rep. 2015 Mar;11(3):2299-305. doi: 10.3892/mmr.2014.2978. Epub 2014 Nov 19.

PMID:
25411767
6.

Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.

Guc D, Canpinar H, Kucukaksu C, Kansu E.

Eur J Haematol. 2000 Jan;64(1):3-9.

PMID:
10680700
7.

mRNA expression of interleukins and Th1/Th2 imbalance in patients with pulmonary embolism.

Duan Q, Lv W, Wang L, Gong Z, Wang Q, Song H, Wang H.

Mol Med Rep. 2013 Jan;7(1):332-6. doi: 10.3892/mmr.2012.1142. Epub 2012 Oct 23.

PMID:
23124310
8.

Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.

Busch C, Girke G, Kohl B, Stoll C, Lemke M, Krasnici S, Ertel W, Silawal S, John T, Schulze-Tanzil G.

Mol Immunol. 2013 Apr;53(4):363-73. doi: 10.1016/j.molimm.2012.09.001. Epub 2012 Oct 13.

PMID:
23070120
9.

Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics.

Wang H, Duan Q, Wang L, Gong Z, Liang A, Wang Q, Song H, Yang F, Song Y.

Int J Med Sci. 2012;9(5):380-6. doi: 10.7150/ijms.4641. Epub 2012 Jul 11.

10.
11.

[The expression and significance of immunity associated genes mRNA in patients with pulmonary embolism].

Gong Z, Liang AB, Wang LM, Zhang XY, Wang Q, Huang CY, Song HM, Wang H, Shen YQ, Gao HJ, Shen XY.

Zhonghua Nei Ke Za Zhi. 2009 Aug;48(8):666-9. Chinese.

PMID:
19954060
12.

Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia.

Barros MM, Yamamoto M, Figueiredo MS, Cançado R, Kimura EY, Langhi DM Jr, Chiattone CS, Bordin JO.

Transfusion. 2009 Jan;49(1):154-60. doi: 10.1111/j.1537-2995.2008.01936.x. Epub 2008 Oct 2.

PMID:
18954403
13.

Renal C3 complement component: feed forward to diabetic kidney disease.

Kelly KJ, Liu Y, Zhang J, Dominguez JH.

Am J Nephrol. 2015;41(1):48-56. doi: 10.1159/000371426. Epub 2015 Jan 30.

14.

Production of multiple transgenic Yucatan miniature pigs expressing human complement regulatory factors, human CD55, CD59, and H-transferase genes.

Jeong YH, Park CH, Jang GH, Jeong YI, Hwang IS, Jeong YW, Kim YK, Shin T, Kim NH, Hyun SH, Jeung EB, Hwang WS.

PLoS One. 2013 May 21;8(5):e63241. doi: 10.1371/journal.pone.0063241. Print 2013.

15.

Genomic characteristics of adhesion molecules in patients with symptomatic pulmonary embolism.

Xie Y, Duan Q, Wang L, Gong Z, Wang Q, Song H, Wang H.

Mol Med Rep. 2012 Sep;6(3):585-90. doi: 10.3892/mmr.2012.940. Epub 2012 Jun 8.

PMID:
22684872
16.
17.

Anaphylatoxin receptors and complement regulatory proteins in human articular and non-articular chondrocytes: interrelation with cytokines.

Schulze-Tanzil G, Kohl B, El Sayed K, Arens S, Ertel W, Stölzel K, John T.

Cell Tissue Res. 2012 Dec;350(3):465-75. doi: 10.1007/s00441-012-1497-2. Epub 2012 Oct 3.

PMID:
23053049
18.

Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.

Spiller OB, Criado-García O, Rodríguez De Córdoba S, Morgan BP.

Clin Exp Immunol. 2000 Aug;121(2):234-41.

19.
20.

Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.

Geis N, Zell S, Rutz R, Li W, Giese T, Mamidi S, Schultz S, Kirschfink M.

Curr Cancer Drug Targets. 2010 Dec;10(8):922-31.

PMID:
20879979
Items per page

Supplemental Content

Write to the Help Desk